BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8864756)

  • 1. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
    Jooss K; Yang Y; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
    Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
    Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
    J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
    Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
    Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
    Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
    Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
    Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
    Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats.
    Lei D; Lehmann M; Shellito JE; Nelson S; Siegling A; Volk HD; Kolls JK
    Hum Gene Ther; 1996 Dec; 7(18):2273-9. PubMed ID: 8953318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-directed gene transfer in non-human primates.
    Sullivan DE; Dash S; Du H; Hiramatsu N; Aydin F; Kolls J; Blanchard J; Baskin G; Gerber MA
    Hum Gene Ther; 1997 Jul; 8(10):1195-206. PubMed ID: 9215737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.
    Tominaga K; Kuriyama S; Yoshiji H; Deguchi A; Kita Y; Funakoshi F; Masaki T; Kurokohchi K; Uchida N; Tsujimoto T; Fukui H
    Gut; 2004 Aug; 53(8):1167-73. PubMed ID: 15247187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung.
    Kaplan JM; Smith AE
    Hum Gene Ther; 1997 Jun; 8(9):1095-104. PubMed ID: 9189767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
    Yang Y; Haecker SE; Su Q; Wilson JM
    Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
    McClane SJ; Chirmule N; Burke CV; Raper SE
    Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.
    Hamada K; Sakaue M; Sarkar A; Buchl S; Satterfield W; Keeling M; Sastry J; Roth JA; Follen M
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S177-86. PubMed ID: 16214207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
    Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
    Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.
    Otake K; Ennist DL; Harrod K; Trapnell BC
    Hum Gene Ther; 1998 Oct; 9(15):2207-22. PubMed ID: 9794205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.